Hsbc Holdings PLC Ptc Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 20,967 shares of PTCT stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,967

Previous 18,918 10.83%

Holding current value

$1.05 Million

Previous $578,000 34.43%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $62,269 - $77,165	2,049 Added 10.83%	20,967 $777,000
Q2 2024 Aug 12, 2024	SELL	$24.69 - $40.12 $105,697 - $171,753	-4,281 Reduced 18.45%	18,918 $578,000
Q1 2024 May 15, 2024	BUY	$24.15 - $31.95 $142,798 - $188,920	5,913 Added 34.21%	23,199 $674,000
Q4 2023 Feb 12, 2024	SELL	$18.07 - $29.37 $236,102 - $383,748	-13,066 Reduced 43.05%	17,286 $476,000
Q3 2023 Nov 13, 2023	SELL	$22.41 - $41.99 $195,303 - $365,942	-8,715 Reduced 22.31%	30,352 $680,000
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $1.02 Million - $1.49 Million	25,241 Added 182.56%	39,067 $1.59 Million
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $1.21 Million - $1.55 Million	-31,740 Reduced 69.66%	13,826 $669,000
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $999,462 - $1.63 Million	29,808 Added 189.16%	45,566 $1.74 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $351,079 - $451,747	-8,389 Reduced 34.74%	15,758 $803,000
Q2 2022 Aug 11, 2022	SELL	$25.6 - $45.23 $966,195 - $1.71 Million	-37,742 Reduced 60.98%	24,147 $969,000
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $295,803 - $395,825	-8,875 Reduced 12.54%	61,889 $2.31 Million
Q4 2021 Feb 11, 2022	BUY	$35.36 - $41.86 $52,686 - $62,371	1,490 Added 2.15%	70,764 $2.82 Million
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $1.55 Million - $1.88 Million	41,941 Added 153.44%	69,274 $2.59 Million
Q2 2021 Aug 13, 2021	BUY	$37.95 - $49.37 $352,935 - $459,141	9,300 Added 51.57%	27,333 $1.16 Million
Q1 2021 May 14, 2021	BUY	$46.8 - $68.92 $513,068 - $755,569	10,963 Added 155.06%	18,033 $853,000
Q4 2020 Feb 12, 2021	SELL	$47.96 - $67.64 $832,393 - $1.17 Million	-17,356 Reduced 71.06%	7,070 $431,000
Q3 2020 Nov 12, 2020	BUY	$45.41 - $57.07 $1.11 Million - $1.39 Million	24,426 New	24,426 $1.16 Million
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $212,757 - $274,845	-4,999 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $5,373 - $9,853	166 Added 3.43%	4,999 $221,000
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $155,719 - $241,988	4,833 New	4,833 $232,000
Q3 2018 Nov 13, 2018	SELL	$33.9 - $47.77 $438,021 - $617,236	-12,921 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$25.7 - $47.88 $332,069 - $618,657	12,921 New	12,921 $436,000

Others Institutions Holding PTCT

# of Institutions

227

Shares Held

78.1M

Call Options Held

144K

Put Options Held

54.8K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.58B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Ptc Therapeutics, Inc. Transaction History